Jericho Assisted Living
Sunday, March 19, 2017
ACC: Factor Xa Inhibitor Plus P2Y12 Inhibitor OK in ACS (CME/CE)
(MedPage Today) -- But results from phase II trial should not change practice
via
ACC: Factor Xa Inhibitor Plus P2Y12 Inhibitor OK in ACS (CME/CE)
by
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment